Morgan Stanley’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.32M | Buy |
652,911
+159,793
| +32% | +$1.06M | ﹤0.01% | 4172 |
|
|
2025
Q1 | $4.51M | Sell |
493,118
-149,484
| -23% | -$1.37M | ﹤0.01% | 4008 |
|
|
2024
Q4 | $6.75M | Sell |
642,602
-365,074
| -36% | -$3.83M | ﹤0.01% | 3732 |
|
|
2024
Q3 | $12M | Buy |
1,007,676
+484,235
| +93% | +$5.79M | ﹤0.01% | 3278 |
|
|
2024
Q2 | $3.01M | Buy |
523,441
+78,394
| +18% | +$451K | ﹤0.01% | 4286 |
|
|
2024
Q1 | $2.31M | Buy |
445,047
+57,989
| +15% | +$302K | ﹤0.01% | 4487 |
|
|
2023
Q4 | $2.04M | Buy |
387,058
+376,404
| +3,533% | +$1.98M | ﹤0.01% | 4913 |
|
|
2023
Q3 | $35.2K | Sell |
10,654
-8,061
| -43% | -$26.6K | ﹤0.01% | 6306 |
|
|
2023
Q2 | $54.1K | Sell |
18,715
-51,248
| -73% | -$148K | ﹤0.01% | 6180 |
|
|
2023
Q1 | $74.9K | Sell |
69,963
-47,129
| -40% | -$50.4K | ﹤0.01% | 6123 |
|
|
2022
Q4 | $306K | Buy |
117,092
+78,448
| +203% | +$205K | ﹤0.01% | 5481 |
|
|
2022
Q3 | $272K | Buy |
38,644
+28
| +0.1% | +$197 | ﹤0.01% | 5578 |
|
|
2022
Q2 | $262K | Buy |
38,616
+7,235
| +23% | +$49.1K | ﹤0.01% | 5761 |
|
|
2022
Q1 | $443K | Sell |
31,381
-27,039
| -46% | -$382K | ﹤0.01% | 5482 |
|
|
2021
Q4 | $847K | Buy |
58,420
+52,170
| +835% | +$756K | ﹤0.01% | 5191 |
|
|
2021
Q3 | $88K | Sell |
6,250
-12,171
| -66% | -$171K | ﹤0.01% | 6442 |
|
|
2021
Q2 | $324K | Buy |
18,421
+17,766
| +2,712% | +$312K | ﹤0.01% | 5764 |
|
|
2021
Q1 | $10K | Buy |
+655
| New | +$10K | ﹤0.01% | 6929 |
|